What is it about?
The research employs structure-based drug design and in silico pharmacological profiling to investigate 101 metabolites from Curcuma caesia rhizomes by selectively targeting cancer-associated proteins MMP9 and GRP78.
Featured Image
Photo by National Cancer Institute on Unsplash
Why is it important?
Our study identifies curcumin and bis-demethoxycurcumin from Curcuma caesia rhizomes as potential inhibitors of two key cancer-associated proteins, MMP9 and GRP78. These proteins drive tumor progression and metastasis. Using molecular docking, molecular dynamics, and pharmacological profiling, we show that both compounds bind strongly, remain stable under physiological conditions, and display favorable drug-like properties with low predicted toxicity. This is important because it highlights specific phytochemicals that could be developed into safer, targeted anti-cancer therapies, and provides a computational framework to accelerate natural product–based drug discovery.
Perspectives
Writing this article was especially rewarding because it brought together my passion for natural product research and my interest in computational drug discovery. Exploring how a traditional medicinal plant like Curcuma caesia might yield compounds that target critical cancer proteins felt like bridging ancient knowledge with modern science. I hope this work inspires others to look at phytochemicals not just as folk remedies but as serious candidates for targeted therapy. More than anything, I see this study as a stepping stone toward developing safer, more precise treatments that could one day make a real difference for cancer patients.
Soham Bhattacharya
Ceska Zemedelska Univerzita v Praze
Read the Original
This page is a summary of: Targeted modulation of MMP9 and GRP78 via molecular interaction and in silico profiling of Curcuma caesia rhizome metabolites: A computational drug discovery approach for cancer therapy, PLOS One, July 2025, PLOS,
DOI: 10.1371/journal.pone.0328509.
You can read the full text:
Contributors
The following have contributed to this page
